504438-08-8

Basic information

• Product Name: (1R,55,6r)-benzyl 6-formyl-3-azabicyclo^3.1.0hexane-3-carboxylate
• Synonyms: (1R,55,6r)-benzyl 6-formyl-3-azabicyclo^3.1.0hexane-3-carboxylate
• CAS NO: 504438-08-8
• Molecular Weight: 245.278
• Mol File: 504438-08-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (1R,55,6r)-benzyl 6-formyl-3-azabicyclo^3.1.0hexane-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,55,6r)-benzyl 6-formyl-3-azabicyclo^3.1.0hexane-3-carboxylate(504438-08-8)
• EPA Substance Registry System: (1R,55,6r)-benzyl 6-formyl-3-azabicyclo^3.1.0hexane-3-carboxylate(504438-08-8)

Safety Data

• Hazardous Substances Data: 504438-08-8(Hazardous Substances Data)

Upstream product

• 146726-10-5 3-benzyl 6-ethyl (1α,5α,6α)-3-azabicyclo[3.1.0]hexane-3,6-dicarboxylate 
• 31970-04-4 1-carboxybenzyl-3-pyrrolidine 
• 501-53-1 benzyl chloroformate 
• 134575-14-7 benzyl (1α,5α,6α)-6-hydroxymethyl-3-azabicyclo[3.1.0]hexan-3-ylcarboxylate 

Downstream Products

• 504438-10-2 benzyl exo-6-(1-hydroxyethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate 
• 681425-64-9 (1S,5R,6s)-benzyl 6-vinyl-3-azabicyclo^3.1.0hexane-3-carboxylate 
• 1251668-93-5 (1α,5α,6α)-6-(2-methoxy-vinyl)-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid benzyl ester 

Relevant articles and documents

ANTIMICROBIAL COMPOUNDS AND METHODS

The invention is directed to compounds that are active as antibacterial agents. The invention compounds are active against gram-positive and gram-negative bacteria and can be used to treat infections caused by gram-positive and gram-negative bacteria. Also disclosed are processes and intermediates for making the compounds.

6-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2-PHENYL-PYRIMIDINES

The present invention relates to 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

Bicyclo[3,1,0]hexane containing oxazolidinone antibioytics and derivatives thereof

Oxazolidinones having a bicyclic[3.1.0] hexane containing moiety, which are effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci, Bacteroides spp., Clostridia spp. species, as well as acid-fa